Table 2

Characteristics and risk of bias assessment for RCT on transfusion therapy in pregnant women with sickle cell disease

Author (year), country, settingSingle vs multicenterDesignYears of studyInclusion criteriaRisk of bias assessment
Koshy (1988)16  Multi RCT Jan 1979 to Mar 1986 HbSS <28 weeks GA Selection bias: Unclear 
United States Only HbSS randomized Excluded neurologic dysfunction, nephrotic syndrome, chronic renal failure, persistent liver disease, chronic lung disease, coagulopathy, or presence of multiple RBC antibodies  
Tertiary care 28 with HbSS not randomized; of those, 7 continued long-term PT initiated prior to study  Performance bias: High risk 
   Detection bias: Unclear 
   Attrition bias: Low risk 
   Reporting bias: Unclear risk 
   Overall: High risk of bias 
Author (year), country, settingSingle vs multicenterDesignYears of studyInclusion criteriaRisk of bias assessment
Koshy (1988)16  Multi RCT Jan 1979 to Mar 1986 HbSS <28 weeks GA Selection bias: Unclear 
United States Only HbSS randomized Excluded neurologic dysfunction, nephrotic syndrome, chronic renal failure, persistent liver disease, chronic lung disease, coagulopathy, or presence of multiple RBC antibodies  
Tertiary care 28 with HbSS not randomized; of those, 7 continued long-term PT initiated prior to study  Performance bias: High risk 
   Detection bias: Unclear 
   Attrition bias: Low risk 
   Reporting bias: Unclear risk 
   Overall: High risk of bias 
Close Modal

or Create an Account

Close Modal
Close Modal